Beam Therapeutics BEAM Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's change in other liabilities?
- Beam Therapeutics (BEAM) reported change in other liabilities of $134K in Q1 2026.
- How has Beam Therapeutics's change in other liabilities changed year-over-year?
- Beam Therapeutics's change in other liabilities increased by 250.6% year-over-year, from -$89K to $134K.
- What is the long-term trend for Beam Therapeutics's change in other liabilities?
- Over 3 years (2021 to 2025), Beam Therapeutics's change in other liabilities has grown at a -43.1% compound annual growth rate (CAGR), from $1.79M to -$330K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.